Fish oil study
This article was originally published in The Tan Sheet
Executive Summary
Fish oil supplements did not protect against irregular heartbeats for patients with implantable cardioverter-defibrillators (ICDs), according to a study published in the Journal of the American Medical Association June 14. The year-long study involved 546 patients with ICDs and prior documented incidences of ventricular tachycardia (VT) or ventricular fibrillation (VF) who received either two grams of fish oil per day, or placebo. Trial endpoints were appropriate ICD intervention for VT or VF, or all-cause mortality. In the fish oil group, 27% required ICD intervention for VT or VF versus 30% in the placebo group. "In contrast to other...[studies], we did not find that fish oil may have proarrhythmic properties," Ingeborg Brouwer, PHD, Wageningen University, the Netherlands, et al., state...